ANI Pharmaceuticals - 48 Year Dividend History | ANIP

Historical dividend payout and yield for ANI Pharmaceuticals (ANIP) since 1971. The current TTM dividend payout for ANI Pharmaceuticals (ANIP) as of April 17, 2019 is $0.00. The current dividend yield for ANI Pharmaceuticals as of April 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.818B $0.202B
ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture and metoclopramide tablets. In addition, it offers contract manufacturing services for other pharmaceutical companies. The company serves through wholesalers, smaller regional distributors and chains and pharmacy and retail outlets primarily in the United States. ANI Pharmaceuticals, Inc., formerly known as BioSante Pharmaceuticals, Inc., is headquartered in Baudette, MN.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.392B 12.66
Gilead Sciences (GILD) United States $80.676B 10.27
Bio-Techne Corp (TECH) United States $7.127B 48.02